Financial Summary (All financials)
| In millions, except per share items | Dec-31-22 | Dec-31-21 | Dec-31-20 | Dec-31-19 | Dec-31-18 | Dec-31-17 | Dec-31-16 | Dec-31-15 |
| Revenues | 12,479.0 | 12,193.0 | 11,066.0 | 11,013.0 | 10,770.0 | 9,998.0 | 9,409.0 | 9,480.0 |
| Revenue growth | 2.3% | 10.2% | 0.5% | 2.3% | 7.7% | 6.3% | -0.7% | -21.3% |
| Cost of goods sold | 8,810.0 | 7,065.0 | 6,196.0 | 6,393.0 | 6,473.0 | 6,351.0 | 5,857.0 | 5,967.0 |
| Gross profit | 3,669.0 | 5,128.0 | 4,870.0 | 4,620.0 | 4,297.0 | 3,647.0 | 3,552.0 | 3,513.0 |
| Gross margin | 29.4% | 42.1% | 44.0% | 42.0% | 39.9% | 36.5% | 37.8% | 37.1% |
| Selling, general and administrative | | | | | | | | |
| General and administrative | 509.0 | 477.0 | 444.0 | 494.0 | 484.0 | 1,691.0 | 1,422.0 | 1,589.0 |
| EBITA | 3,782.0 | 2,237.0 | 3,027.0 | 2,561.0 | 2,137.0 | 1,769.0 | 1,968.0 | 1,761.0 |
| EBITA margin | 30.3% | 18.3% | 27.4% | 23.3% | 19.8% | 17.7% | 20.9% | 18.6% |
| Amortization of intangibles | 113.0 | 147.0 | 246.0 | 392.0 | 593.0 | 704.0 | 157.0 | 174.0 |
| EBIT | 3,669.0 | 2,090.0 | 2,781.0 | 2,169.0 | 1,544.0 | 1,065.0 | 1,811.0 | 1,587.0 |
| EBIT margin | 29.4% | 17.1% | 25.1% | 19.7% | 14.3% | 10.7% | 19.2% | 16.7% |
| Pre-tax income | 3,156.0 | 1,931.0 | 2,466.0 | 1,870.0 | 1,246.0 | 685.0 | 1,401.0 | 1,428.0 |
| Income taxes | 510.0 | 623.0 | 448.0 | 297.0 | 146.0 | 250.0 | 148.0 | 175.0 |
| Tax rate | 16.2% | 32.3% | 18.2% | 15.9% | 11.7% | 36.5% | 10.6% | 12.3% |
| Earnings from continuing ops | 2,646.0 | 1,255.0 | 1,969.0 | 1,532.0 | 1,060.0 | 398.0 | 1,219.0 | 1,216.0 |
| Earnings from discontinued ops | | | | | 74.0 | 828.0 | 177.0 | 169.0 |
| Net income | 2,646.0 | 1,255.0 | 1,969.0 | 1,532.0 | 1,134.0 | 1,226.0 | 1,396.0 | 1,385.0 |
| Net margin | 21.2% | 10.3% | 17.8% | 13.9% | 10.5% | 12.3% | 14.8% | 14.6% |
| |
| Diluted EPS | | $5.55 | $8.45 | $6.37 | $4.29 | $1.53 | $4.51 | $4.28 |
| Shares outstanding (diluted) | | 226.1 | 233.1 | 240.6 | 247.0 | 260.7 | 270.3 | 283.8 |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|